Kinsale Capital Group (KNSL)
(Delayed Data from NYSE)
$426.03 USD
-2.08 (-0.49%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $425.95 -0.08 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
KNSL 426.03 -2.08(-0.49%)
Will KNSL be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for KNSL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KNSL
Reinsurance Group Q3 Earnings Beat Estimates on Higher Revenues
Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now?
KNSL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Allstate Q3 Earnings Beat on Strong Premium and Investment Income
SKWD or KNSL: Which Is the Better Value Stock Right Now?
Prudential Financial Q3 Earnings Beat Estimates, Revenues Rise Y/Y
Other News for KNSL
TD Cowen Sticks to Their Hold Rating for Kinsale Capital Group (KNSL)
Kinsale Capital Group (KNSL) Gets a Hold from J.P. Morgan
Unveiling 5 Analyst Insights On Kinsale Cap Gr
Coinbase initiated, Edwards Lifesciences upgraded: Wall Street’s top analyst cal
Coinbase initiated, Edwards Lifesciences upgraded: Wall Street's top analyst cal